Abstract
In 1976 Borel first described the potent immunosuppressive activity of cyclosporin A (CsA) and its apparent selective action on T lymphocyte-dependent cell-mediated immune responses1,2. Within a decade of these initial observations CsA has become the front-line immunosuppressive agent to prevent solid organ graft rejection and graft-versus-host disease in clinical transplantation3. Its usefulness is currently being evaluated in a wide variety of autoimmune disorders with some remarkable successes4,5. Despite the wide empiric application of CsA, the precise mechanism of action of this drug remains elusive. Nevertheless, many studies have provided some insight into the action of this unique immunosuppressive drug on the cells of the immune system which mediate the events of graft rejection. It has become increasingly apparent that one of the primary actions of CsA is on the interleukin-2 (IL-2)/interleukin-2 receptor autocrine pathway. This chapter will attempt to summarize the salient features of the effects of CsA on the complex cellular events necessary for a competent immune response with a particular focus on the IL-2/IL-2 receptor pathway.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Borel, J. F. (1976) Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity. Immunology, 31, 631
Borel, J. F., Feurer, C., Gubler, H. U. and Stahelin, H. (1976) Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions, 6, 468
Morris, P. J. (1981) Cyclosporin A. Transplantation, 32, 349
Schindler, R. (ed.) (1985) Ciclosporin in Autoimmune Diseases (Berlin: Springer-Verlag)
Stiller, G R., Durpe, J., Gent, M., jenner, M. R., Keown, P. A., Laupacis, A., Martell, R., Rodger, N. W., von Graffenreid, B. and Wolfe, B. M. J. (1984) Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science, 223, 1362
Hess, A. D., Colombani, P. M. and Esa, A H. (1986) Cyclosporin and the immune response: basic aspects. Crit. Rev. Immunol., 6, 123
Green, G. L. and Allison, A. C. (1978) Extensive prolongation of rabbit kidney allograft survival after short-term Cyclosporin A treatment. Lancet, 1, 1182
Hess, A. D., Esa, A. H. and Colombani, P. M. (1985) Mechanisms of action of cyclosporine: Effect on cells of the immune system and on subcellular events in T cell activation. Trans. Proc., 20 (Suppl. 2), 29
Bunjes, D., Hardt, C., Rollinghoff, M. and Wagner, H. (1981) Cyclosporin A mediates immunosuppesslon, of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur. J. Immunol., 8, 657
Hess, A. D., Tutschka, P. J., Pu, Z. and Santos, G. W. (1982) Effect of cyclosporine A on human lymphocyte responses in vitro. IV. Production of stimulatory growth factor in CsA treated primary MLR cultures. J. Immunol., 128, 360
Hess, A. D. (1985) Effect of interleukin 2 on the immunosuppressive action of cyclosporine. Transplantation, 39, 62
Thomson, A. W., Moon, D. K. and Nelson, D. S. (1983) Suppression of delayed type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse. Clin. Exp. Immunol., 52, 599
Wang, G. S., Zheng, C., Heacock, E. H., Tilney, N. L., Strom, T. B. and Mannick, J. A. (1983) Inhibition of the production of a soluble helper mediator by cyclosporin A results in the failure to generate alloreactive cytolytic cells in mixed-lymphocyte culture. Clin. Immunol Immunopathol., 27, 160
Hess, A. D., Tutschka, P. J. and Santos, G. W. (1983) Effect of cyclosporine on the induction of cytotoxic T lymphocytes: Role of interleukin 1 and interleukin 2. Transplant. Proc., 15, 2248
Palacios, R. and Moller, G. (1981) Cyclosporin A blocks receptors for HLA-DR antigens on T cells. Nature, 290, 792
Andrus, L. and Lafferty, K. J. (1981) Inhibition of T-cell activity by cyclosporin A. Scand. J. Immunol., 15, 449
Hess, A. D., Tutschka, P. J. and Santos, G. W. (1982) Effect of cyclosporin on human lymphocyte response in vitro. III. CS inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF. J. Immunol., 128, 355
Elliott, J. F., Lin, Y., Mizel, S. B., BleacHey, R. C., Hamish, D. G. and Paetkau, V. (1984) Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science, 226, 1439
Granelli-Pipemo, A., Inaba, K. and Steinman, R. (1984) Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A. J. Exp. Med., 160, 1792
Granelli-Pipemo, A. (1988) In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence and absence of CsA.J. Exp. Med., 168, 1649
Borel, J. F. and Ryffel, B. (1986) The mechanism of action of cyclosporin: a continuing puzzle. In Schindler, R. (ed.), Ciclosporin in Autoimmune Diseases, (Berlin: Springer-Verlag), pp. 24–32
Weissm, A. and Imboden, J. (1987) Cell surface molecules and early events in T lymphocyte activation. Adv. Immunol., 41, 1
Hodgkin, P. D., Hapel, A. J., Johnson, R. M., Young, I. G. and Lafferty, K. J. (1987) Blocking of the delivery of the antigen-mediated signal to the nucleus of T cells by Cyclosporine. Transplantation, 43, 685
Citterio, F. and Kahan, B. P. (1988) Effects of cyclosporine on nuclear function. Trans. Proc., 20 (Suppl. 2), 75
June, C H., Ledbetter, J. A., Gellespie, M. M., Llndtsen, T. and Thompson, C. B. (1987) T cell proliteration involving the CD 28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Molec. Cell. Biol., 7, 4472
Reed, J. C., Prystowsky, M. B. and Nowell, P. C. (1988) Regulation of gene expression in lectin-stimulated or lymphokine-sttimulated T lymphocytes. Transplantation, 26 (Suppl.), 85
Larsson, E. L. (1980) Cyclosporin A and dexmethansone suppress T cell responses by selectively acting at distinct sites of the triggering process. J. Immunol., 124, 2828
Wagner, H. (1983) Cyclosporine A: mechanism of action. Transplant. Proc., 15, 523
Hess, A. D. and Tutschka, P. J. (1980) Effects of cyclosporine A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells whilep referentially inhibiting the induction of cytolytic effector lymphocytes in MLR. J. Immunol., 124, 2601
Heeg, K., Gillis, S. and Wagner, N. (1988) IL-4 bypassed the immune suppressive effect of Cyclosporin A during the in vitro induction of immune cytotoxic T lymphocytes. J. Immunol., 141, 2330
Wagner, H., Hardt, C., Rouse, B., Rollinghoff, M., Scheurich, P. and Pfizermaier, F. (1982) Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses. J. Exp. Med., 155, 1876
Miyawaki, T., Yachie, A., Ohzeki, S., Nagoaki, T. and Taniguchi, N. (1983) Cyclosporin A does not prevent expression of TAC antigen, a probable TCGF receptor molecule on mitogen stimulated human T cells, J. Immunol., 130, 2737
Ryffel, B., Tammi, K., Greider, A. and Hess, A. D. (1985) Effects of cyclosporine on human T cell activation. Transplant Proc., 17, 1268
Hess, A. D., Donnenberg, A. D., Tutschka, P. J. and Santos, G. W. (1983) Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocytes subpopuiation in primary MLR with monoclonal antibodies. J. Immunol., 130, 717
Lillehoj, H. S., Malek, T. R. and Shevach, E. M. (1984) Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens. J. Immunol., 133, 244
White, D. J. G. (1982) Pharmacology of cyclosporin A. Drugs, 24, 322
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Hess, A.D. (1989). Effect of cyclosporin A on the immune response: pivotal role of the interleukin-2/ interleukin-2 receptor autocrine pathway. In: Thomson, A.W. (eds) Cyclosporin. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0859-8_2
Download citation
DOI: https://doi.org/10.1007/978-94-009-0859-8_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6874-1
Online ISBN: 978-94-009-0859-8
eBook Packages: Springer Book Archive